Charles River Laboratories International, Inc. (CRL)

CRL Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 28, 2024	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020	Dec 28, 2019
Revenue	4,061	4,129	3,976	3,540	2,924	2,621
Revenue Growth (YoY)	-3.67%	3.86%	12.31%	21.08%	11.55%	15.67%
Cost of Revenue	2,602	2,600	2,508	2,203	1,850	1,656
Gross Profit	1,459	1,529	1,468	1,337	1,074	965.03
Selling, General & Admin	719.13	735.57	654.61	578.23	522.59	487.69
Operating Expenses	850.4	873.01	801.18	703.08	634.47	577.23
Operating Income	608.62	656.17	666.48	634.39	439.08	387.8
Interest Expense	-131.6	-136.71	-59.29	-73.91	-86.43	-60.88
Interest & Investment Income	8.33	5.2	0.78	0.65	0.83	1.52
Earnings From Equity Investments	120.53	97.83	-26.78	-30.42	100.86	20.71
Currency Exchange Gain (Loss)	-	-	-46.53	-31.83	-	-
Other Non Operating Income (Expenses)	-100.99	-96.68	-18.4	7.79	13.09	-7.22
EBT Excluding Unusual Items	504.89	525.81	516.27	506.67	467.43	341.92
Merger & Restructuring Charges	-83.82	-42.06	-16.68	-45.96	-10.01	-37.84
Gain (Loss) on Sale of Assets	-0.96	-0.96	123.41	20	-	-
Other Unusual Items	98.5	98.5	-	-	-10.3	-
Pretax Income	518.61	581.28	622.99	480.71	447.11	304.08
Income Tax Expense	90.62	100.91	130.38	81.87	81.81	50.02
Earnings From Continuing Operations	427.99	480.37	492.61	398.84	365.31	254.06
Net Income to Company	427.99	480.37	492.61	398.84	365.31	254.06
Minority Interest in Earnings	-4.21	-5.75	-6.38	-7.86	-1	-2.04
Net Income	423.78	474.62	486.23	390.98	364.3	252.02
Net Income to Common	413.08	474.62	486.23	390.98	364.3	252.02
Net Income Growth	-10.77%	-2.39%	24.36%	7.32%	44.55%	11.33%
Shares Outstanding (Basic)	51	51	51	50	50	49
Shares Outstanding (Diluted)	52	51	51	51	51	50
Shares Change (YoY)	0.31%	0.29%	-0.24%	1.61%	1.85%	1.38%
EPS (Basic)	8.03	9.27	9.57	7.77	7.35	5.17
EPS (Diluted)	8.00	9.22	9.48	7.60	7.20	5.07
EPS Growth	-13.25%	-2.74%	24.74%	5.56%	42.01%	9.72%
Free Cash Flow	560.48	365.37	294.91	532.03	380.02	340.42
Free Cash Flow Per Share	10.86	7.10	5.75	10.35	7.51	6.85
Gross Margin	35.93%	37.03%	36.91%	37.78%	36.72%	36.82%
Operating Margin	14.99%	15.89%	16.76%	17.92%	15.02%	14.79%
Profit Margin	10.17%	11.49%	12.23%	11.04%	12.46%	9.61%
Free Cash Flow Margin	13.80%	8.85%	7.42%	15.03%	13.00%	12.99%
EBITDA	948.77	970.29	970.35	899.93	674	585.9
EBITDA Margin	23.36%	23.50%	24.40%	25.42%	23.05%	22.35%
D&A For EBITDA	340.15	314.12	303.87	265.54	234.92	198.1
EBIT	608.62	656.17	666.48	634.39	439.08	387.8
EBIT Margin	14.99%	15.89%	16.76%	17.92%	15.02%	14.79%
Effective Tax Rate	17.47%	17.36%	20.93%	17.03%	18.30%	16.45%
Revenue as Reported	4,061	4,129	3,976	3,540	2,924	2,621

Source: S&P Capital IQ. Standard template. Financial Sources.